“They introduced options that FDA wasn’t considering, that are too weak,” Michael Patoka, a policy analyst for the Center for Progressive Reform, told Food Safety News. [read post]

 This post draws from a recent report she wrote together with Michael Patoka, a law student at the University of Maryland’s Francis King Carey School of Law and an intern at CPR, and James Goodwin, a Policy Analyst with CPR. [read post]